购物车
- 全部删除
- 您的购物车当前为空
VIP236,作为一种小分子药物偶联物 (SMDCs),其结构包括αvβ3整合素结合剂及经优化的喜树碱拓扑异构酶 I (TOP1) 抑制剂.该化合物针对αvβ3整合素,展现出抗癌活性,能在肿瘤微环境中通过中性粒细胞弹性蛋白酶的裂解作用来释放载荷.
VIP236,作为一种小分子药物偶联物 (SMDCs),其结构包括αvβ3整合素结合剂及经优化的喜树碱拓扑异构酶 I (TOP1) 抑制剂.该化合物针对αvβ3整合素,展现出抗癌活性,能在肿瘤微环境中通过中性粒细胞弹性蛋白酶的裂解作用来释放载荷.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | VIP236 is a small molecule drug conjugate (SMDCs) composed of an αvβ3 integrin binder linked to an optimized camptothecin topoisomerase I (TOP1) inhibitor payload. This compound exerts anticancer activity by targeting αvβ3 integrin and allows for the payloads release upon cleavage by neutrophil elastase in the tumor microenvironment. |
分子量 | 1515.55 |
分子式 | C72H84N12Na2O20S |
CAS No. | 2418533-90-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容